This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Children's Hospital of Philadelphia. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Eiko Nakamaru-Ogiso: Innovator in Mitochondrial Research
Introduction
Eiko Nakamaru-Ogiso is a prominent inventor based in Philadelphia, PA, known for his contributions to the field of mitochondrial research. His work focuses on developing compositions and methods for treating mitochondrial respiratory chain dysfunction and other related disorders. With a single patent to his name, Nakamaru-Ogiso is making strides in understanding and addressing these complex health issues.
Latest Patents
Eiko Nakamaru-Ogiso holds a patent titled "Compositions and methods for treatment of mitochondrial respiratory chain dysfunction and other mitochondrial disorders." This patent provides innovative compositions and methods aimed at treating mitochondrial respiratory chain dysfunction. Additionally, it discloses several screening assays that are useful for identifying agents that can modulate the phenotype associated with these dysfunctions.
Career Highlights
Nakamaru-Ogiso is affiliated with The Children's Hospital of Philadelphia, where he contributes to groundbreaking research in pediatric health. His work is vital in advancing the understanding of mitochondrial disorders, which can have significant impacts on children's health and development.
Collaborations
One of his notable collaborators is Marni J Falk, who is also involved in research related to mitochondrial disorders. Their partnership exemplifies the collaborative spirit in the scientific community, particularly in addressing complex health challenges.
Conclusion
Eiko Nakamaru-Ogiso is a dedicated inventor whose work in mitochondrial research is paving the way for new treatments and understanding of mitochondrial disorders. His contributions are essential in the ongoing quest to improve health outcomes for affected individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
